News

Dublin, March 31, 2025 (GLOBE NEWSWIRE) -- The "Butorphanol (CAS 42408-82-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ...
As we previously reported, Amgen and Hospira both filed motions asking the Court to partially set aside the jury verdict in the Amgen v. Hospira litigation. In its motion, Hospira had asked the ...
Importantly, Hospira believes the market for its specialty injectable drugs could grow for years to come. Since 2012, the company has filed for regulatory approval of 150 molecules; in its recent ...
Pfizer agreed to buy Hospira in a $16 billion, all-cash deal that would expand the New York pharmaceutical company’s sales of injectable drugs and lower-priced versions of costly biotech drugs.
Hospira: Court Considers Issues Regarding the Scope of Discovery and the RPS’s Ability to Assert Additional Patents in BPCIA Actions Goodwin + Follow x Following x Following - Unfollow Contact ...
Hospira’s version, Retacrit, was the bulk of revenue in a fast-growing biosimilar franchise that had more than $100 million in 2013 sales, which have been growing by double-digit percentages.
Abstract and Introduction. Purpose: The pharmacokinetics and tolerability of single and multiple doses of intranasal butorphanol tartrate using a single-dose, metered sprayer were studied. Methods ...
Pfizer has agreed to buy Hospira, the top provider of injectable drugs, for $15.2 billion, in a move to expand its global product portfolio, the companies announced Thursday.
Lake Forest-based hospital products-maker Hospira Inc. said Thursday it completed the $2.1 billion acquisition of Mayne Pharma Ltd., an Australian maker of generic cancer medicines and other specia… ...
Hospira has emerged as a bidder for Danone's medical-nutrition unit in a deal that could be worth about $5 billion and mark the latest in a flurry of so-called inversion deals.
The butorphanol tartrate solution evaluated in this study is very similar to Stadol NS solution but lacks a preservative (0.008% benzethonium chloride in Stadol NS) used in the multidose bottle ...